JP2008526840A5 - - Google Patents

Download PDF

Info

Publication number
JP2008526840A5
JP2008526840A5 JP2007550328A JP2007550328A JP2008526840A5 JP 2008526840 A5 JP2008526840 A5 JP 2008526840A5 JP 2007550328 A JP2007550328 A JP 2007550328A JP 2007550328 A JP2007550328 A JP 2007550328A JP 2008526840 A5 JP2008526840 A5 JP 2008526840A5
Authority
JP
Japan
Prior art keywords
amino
sulfonyl
carbonyl
ethyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007550328A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008526840A (ja
Filing date
Publication date
Priority claimed from GB0500140A external-priority patent/GB0500140D0/en
Priority claimed from GB0521484A external-priority patent/GB0521484D0/en
Application filed filed Critical
Priority claimed from PCT/SE2006/000010 external-priority patent/WO2006073361A1/en
Publication of JP2008526840A publication Critical patent/JP2008526840A/ja
Publication of JP2008526840A5 publication Critical patent/JP2008526840A5/ja
Pending legal-status Critical Current

Links

JP2007550328A 2005-01-06 2006-01-04 新規化合物 Pending JP2008526840A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0500140A GB0500140D0 (en) 2005-01-06 2005-01-06 Novel compounds
GB0521484A GB0521484D0 (en) 2005-10-21 2005-10-21 Novel compounds
PCT/SE2006/000010 WO2006073361A1 (en) 2005-01-06 2006-01-04 Novel pyridine compounds

Publications (2)

Publication Number Publication Date
JP2008526840A JP2008526840A (ja) 2008-07-24
JP2008526840A5 true JP2008526840A5 (https=) 2008-12-25

Family

ID=36647772

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007550328A Pending JP2008526840A (ja) 2005-01-06 2006-01-04 新規化合物

Country Status (15)

Country Link
US (1) US20090227555A2 (https=)
EP (1) EP1836189A1 (https=)
JP (1) JP2008526840A (https=)
KR (1) KR20070107024A (https=)
AR (1) AR055554A1 (https=)
AU (1) AU2006204159A1 (https=)
BR (1) BRPI0606437A (https=)
CA (1) CA2594255A1 (https=)
IL (1) IL183961A0 (https=)
MX (1) MX2007008237A (https=)
NO (1) NO20073101L (https=)
RU (1) RU2007129779A (https=)
TW (1) TW200626593A (https=)
UY (1) UY29325A1 (https=)
WO (1) WO2006073361A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2008101924A (ru) * 2005-07-13 2009-08-20 Астразенека Аб (Se) Новые аналоги пиридина
US20080009523A1 (en) * 2006-07-04 2008-01-10 Astrazeneca Ab New Pyridine Analogues IV
WO2008004945A1 (en) * 2006-07-04 2008-01-10 Astrazeneca Ab Novel crystalline forms i and ii
US20080032992A1 (en) * 2006-07-04 2008-02-07 Astrazeneca Ab New Pyridine Analogues V
WO2008004944A1 (en) * 2006-07-04 2008-01-10 Astrazeneca Ab Novel crystalline form ii
TW200811133A (en) * 2006-07-04 2008-03-01 Astrazeneca Ab New pyridine analogues III 334
UY30868A1 (es) * 2007-01-12 2008-09-02 Astrazeneca Ab Nuevos compuestos de piridina, composiciones farmacéuticas conteniéndolas y aplicaciones.
US20100137277A1 (en) * 2007-01-12 2010-06-03 Astrazeneca Ab Pyridine compounds and their use as p2y12 antagonists
AR064864A1 (es) * 2007-01-12 2009-04-29 Astrazeneca Ab Compuestos analogos de piridina vii 543 y composicion farmaceutica
CN101679358B (zh) * 2007-06-18 2013-10-30 塞诺菲-安万特股份有限公司 作为p2y12拮抗剂的吡咯衍生物
US20090018166A1 (en) * 2007-07-13 2009-01-15 Astrazeneca Ab New Pyridine Analogues X 161
AR074628A1 (es) * 2008-07-07 2011-02-02 Astrazeneca Ab Derivados de piridina 2- amino-6-alquil sustituidos utiles como inhibidores de p2y12 308
WO2011002067A1 (ja) * 2009-07-02 2011-01-06 武田薬品工業株式会社 複素環化合物およびその用途
JP2014051434A (ja) * 2010-12-28 2014-03-20 Dainippon Sumitomo Pharma Co Ltd 二環性ピリミジン誘導体
WO2013033178A1 (en) 2011-08-30 2013-03-07 University Of Utah Research Foundation Methods and compositions for treating nephrogenic diabetes insipidus
TW201412728A (zh) 2012-08-21 2014-04-01 Hoffmann La Roche 新穎吡啶衍生物
GB201604970D0 (en) 2016-03-23 2016-05-04 Syngenta Participations Ag Improvements in or relating to organic compounds
CN118076585A (zh) * 2021-07-23 2024-05-24 国家医疗保健研究所 革兰氏阴性菌外排泵抑制剂
WO2024121138A1 (en) 2022-12-06 2024-06-13 Idorsia Pharmaceuticals Ltd Crystalline adipic acid salt form of a ccr6 antagonist

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE288444T1 (de) * 1995-05-29 2005-02-15 Pfizer Dipeptide, die die ausschüttung von wachstumshormonen stimulieren
EP1009405A4 (en) * 1997-08-28 2001-05-09 Merck & Co Inc PAYRROLIDINE AND PIPERIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
US6156758A (en) * 1999-09-08 2000-12-05 Isis Pharmaceuticals, Inc. Antibacterial quinazoline compounds
DK1257550T3 (da) * 2000-02-04 2006-03-27 Portola Pharm Inc Blodplade-ADP-receptor-inhibitor
US6906063B2 (en) * 2000-02-04 2005-06-14 Portola Pharmaceuticals, Inc. Platelet ADP receptor inhibitors
US7132408B2 (en) * 2000-08-21 2006-11-07 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7452870B2 (en) * 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound
US7018985B1 (en) * 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
FR2820057A1 (fr) * 2001-01-30 2002-08-02 Ct De Transfert De Technologie Membrane pour chambre d'encapsulation de cellules produisant au moins une substance biologiquement active et organe bio-artificiel comprenant une telle membrane
AU2002336462A1 (en) * 2001-09-06 2003-03-24 Millennium Pharmaceuticals, Inc. Piperazine and homopiperazine compounds
AR037097A1 (es) * 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
GB0312609D0 (en) * 2003-06-02 2003-07-09 Astrazeneca Ab Novel compounds
US7504497B2 (en) * 2003-10-21 2009-03-17 Inspire Pharmaceuticals, Inc. Orally bioavailable compounds and methods for inhibiting platelet aggregation
US7335648B2 (en) * 2003-10-21 2008-02-26 Inspire Pharmaceuticals, Inc. Non-nucleotide composition and method for inhibiting platelet aggregation
US7749981B2 (en) * 2003-10-21 2010-07-06 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
US8071624B2 (en) * 2004-06-24 2011-12-06 Incyte Corporation N-substituted piperidines and their use as pharmaceuticals
US20080009523A1 (en) * 2006-07-04 2008-01-10 Astrazeneca Ab New Pyridine Analogues IV
MX2008016562A (es) * 2006-07-04 2009-02-06 Astrazeneca Ab Analogos de piridina nuevos.
US20080032992A1 (en) * 2006-07-04 2008-02-07 Astrazeneca Ab New Pyridine Analogues V

Similar Documents

Publication Publication Date Title
JP2008526840A5 (https=)
RU2007129779A (ru) Новые соединения пиридина
JP2006500348A5 (https=)
JP2007516173A5 (https=)
JP6503336B2 (ja) シアノトリアゾール化合物
JP2007531752A5 (https=)
AU2020202167A1 (en) Pyrazolyl-substituted pyridone compounds as serine protease inhibitors
JP2006500369A5 (https=)
JP2012526803A5 (https=)
JP2010513444A5 (https=)
JP2016135778A (ja) シアノトリアゾール化合物の医薬用途
CA2396824A1 (en) Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2
JP2010513304A5 (https=)
JP2007519735A5 (https=)
JP2010514677A5 (https=)
MX2012008280A (es) Compuestos y metodos.
JP2016523925A5 (https=)
AU2005230901A1 (en) Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP)
JP2007508346A5 (https=)
HRP20170019T1 (hr) Novi pirol-inhibitori od reduktaze s-nitrozoglutationa kao terapeutska sredstva
RU2004112191A (ru) Лактамсодержащие соединения и их производные в качестве ингибиторов фактора ха
AU2003255724A1 (en) Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
JP2007523905A5 (https=)
JP2007528887A5 (https=)
RU2007107349A (ru) Пиперазиновые производные, применение для лечения желудочно-кишечных расстройств